1
2
3
van Opijnen, Mark P., Broekman, Marike L.D., Cuppen, Edwin, Dubbink, Hendrikus J., ter Elst, Arja, van Eijk, Ronald, Mühlebner, Angelika, Jansen, Casper, van der Geize, Robert, Speel, Ernst Jan M., Groenen, Patricia J.T.A., de Vos, Filip Y.F., Wesseling, Pieter, de Leng, Wendy W.J., Maas, Sybren L.N.
Veröffentlicht in: van Opijnen , M P , Broekman , M L D , Cuppen , E , Dubbink , H J , ter Elst , A , van Eijk , R , Mühlebner , A , Jansen , C , van der Geize , R , Speel , E J M , Groenen , P J T A , de Vos , F Y F , Wesseling , P , de Leng , W W J & Maas , S L N 2024 , ' Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands : interlaboratory variation in the primary diagnostic and recurrent setting ' , JOURNAL OF NEURO-ONCOLOGY , vol. 166 , pp. 485–492 . https://doi.org/10.1007/s11060-024-04568-8;
2024
Veröffentlicht in: van Opijnen , M P , Broekman , M L D , Cuppen , E , Dubbink , H J , ter Elst , A , van Eijk , R , Mühlebner , A , Jansen , C , van der Geize , R , Speel , E J M , Groenen , P J T A , de Vos , F Y F , Wesseling , P , de Leng , W W J & Maas , S L N 2024 , ' Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands : interlaboratory variation in the primary diagnostic and recurrent setting ' , JOURNAL OF NEURO-ONCOLOGY , vol. 166 , pp. 485–492 . https://doi.org/10.1007/s11060-024-04568-8;
2024
4
5
6
7
van der Weide, H.L. (Hiska L.), Kramer, M.C.A. (Miranda C.A.), Scandurra, D. (Daniel), Eekers, D.B.P. (Daniëlle B.P.), Klaver, Y.L. (Yvonne L.), Wiggenraad, R. (Ruud), Méndez Romero, A.M. (Alejandra), Coremans, I.E.M. (Ida E.M.), Boersma, L. (Liesbeth), Van Vulpen, M., Langendijk, J.A. (Johannes)
2021
2021
8
9
10
Beije, N., Kraan, J., Taal, W., van der Holt, B., Oosterkamp, H. M., Walenkamp, A. M., Beerepoot, L., Hanse, M., van Linde, M. E., Otten, A., Vernhout, R. M., de Vos, F. Y. F., Gratama, J. W., Sleijfer, S., van den Bent, M. J.
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , B , Oosterkamp , H M , Walenkamp , A M , Beerepoot , L , Hanse , M , van Linde , M E , Otten , A , Vernhout , R M , de Vos , F Y F , Gratama , J W , Sleijfer , S & van den Bent , M J 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Jounal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , B , Oosterkamp , H M , Walenkamp , A M , Beerepoot , L , Hanse , M , van Linde , M E , Otten , A , Vernhout , R M , de Vos , F Y F , Gratama , J W , Sleijfer , S & van den Bent , M J 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Jounal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015